Format

Send to

Choose Destination
See comment in PubMed Commons below
Hematol Oncol Clin North Am. 1994 Feb;8(1):113-9.

New directions for breast cancer therapeutic research.

Author information

1
Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland.

Abstract

For the past two decades, attempts to improve chemotherapy for patients with breast cancer have emphasized the use of currently available agents. Research by drug discovery programs of the National Cancer Institute has identified a number of clinically promising novel agents. Conceivably, within the next several years there could be a doubling of the chemotherapy armamentarium for breast cancer--more than 30 active cytotoxic agents.

PMID:
8150774
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center